Use of CT post-mortem examinations
This policy statement sets out the HTA’s position on the use of CT (computer tomography) post-mortem examinations. It has been developed as a result of technological advances in CT post-mortem examinations.
Professionals carrying out CT post-mortem examinations can refer to this and identify whether a HTA license is required.
We are reviewing licencing requirements for the use of non-invasive CT in determining cause of death. Any changes to our position will be incorporated into Code B: Post-mortem examination.
HTA annual report and accounts 2024/25
The Human Tissue Authority (HTA) annual report and accounts from 1 April 2024 to 31 March 2025 has been published.
It includes performance, achievements and analysis; corporate governance report and statement; financial statements and an accountability and audit report.
For further information: Human Tissue Authority annual report and accounts: 2024 to 2025 - GOV.UK
HTA statement on the Fuller Independent Inquiry phase two report
Statement from Chief Executive Dr Colin Sullivan
HTA approves 88 living organ donations in June 2025
In June, a total of 88 living organ donations were approved across all four nations.